tiprankstipranks
NervGen Pharma (NGEN)
NASDAQ:NGEN
US Market
NGEN
NervGen Pharma
RESEARCH TOOLSreports
Want to see NGEN full AI Analyst Report?

NervGen Pharma (NGEN) Stock News & Sentiment

93 Followers
NervGen Pharma Launches Underwritten Public Offering to Fund NVG-291 Development
Premium
Company Announcements
NervGen Pharma Launches Underwritten Public Offering to Fund NVG-291 Development
2d ago
6K
NGEN
NervGen Pharma Advances NVG-291 Toward Registrational Trial as Q1 2026 Loss Narrows
Premium
Company Announcements
NervGen Pharma Advances NVG-291 Toward Registrational Trial as Q1 2026 Loss Narrows
6d ago
6K
NGEN
NervGen Pharma Narrows Quarterly Loss but Cash Reserves Decline in Q1 2026 Filing
Premium
Company Announcements
NervGen Pharma Narrows Quarterly Loss but Cash Reserves Decline in Q1 2026 Filing
9d ago
6K
NGEN
NervGen Pharma Names New CFO and Wins Shareholder Backing for 2026 Equity Plan
Premium
Company Announcements
NervGen Pharma Names New CFO and Wins Shareholder Backing for 2026 Equity Plan
27d ago
6K
NGEN
NervGen Wins FDA Alignment for Phase 3 RESTORE Trial in Chronic Tetraplegia
Premium
Company Announcements
NervGen Wins FDA Alignment for Phase 3 RESTORE Trial in Chronic Tetraplegia
2M ago
NGEN
NervGen Pharma: Buy Rating on De‑Risked Path to Pivotal NVG-291 Trials and Compelling Risk‑Reward in Chronic Spinal Cord Injury
Premium
Ratings
NervGen Pharma: Buy Rating on De‑Risked Path to Pivotal NVG-291 Trials and Compelling Risk‑Reward in Chronic Spinal Cord Injury
2M ago
NGEN
NervGen Maps Path to Phase 3 as NVG-291 Data Strengthen Neuroreparative Ambitions
Premium
Company Announcements
NervGen Maps Path to Phase 3 as NVG-291 Data Strengthen Neuroreparative Ambitions
2M ago
NGEN
More NGEN News >

NGEN News on the Web

NervGen Pharma Advances NVG-291 Toward Registrational Trial as Q1 2026 Loss Narrows
TipRanks News
Bullish
NervGen Pharma reports Q1 EPS (2c), consensus (7c)
TipRanks News
Bullish
NervGen Pharma Narrows Quarterly Loss but Cash Reserves Decline in Q1 2026 Filing
TipRanks News
Neutral
NervGen Pharma (NGEN) Gets a Buy from Stifel Nicolaus
TipRanks News
Neutral
NervGen Pharma Names New CFO and Wins Shareholder Backing for 2026 Equity Plan
TipRanks News
Neutral
NervGen Pharma appoints Keith Vendola as CFO
TipRanks News
Neutral
NervGen Pharma initiated with a Buy at H.C. Wainwright
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: NervGen Pharma (NGEN), Atai Beckley N.V. (ATAI) and Journey Medical Corp (DERM)
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
NGEN
Sector Average
Media Buzz
This Week6 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average80%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NGEN’s Media Buzz Sentiment?
6 articles about NGEN were published this week. In an average week, 2 articles are published.
    What is NGEN’s weekly average amount of articles?
    In an average week, 2 articles about NGEN are published.
      What is NGEN’s News Sentiment?
      100% of articles about NGEN were positive this week, compared to its sector average of 80%.
        Healthcare Stocks that are Trending in the News
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        TLSATiziana Life Sciences
        JUNSJupiter Neurosciences, Inc.
        IMMXImmix Biopharma
        Showing the stocks with the most bullish news sentiment over the past week